An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques
2016 · Nature Communications · 389 citations
https://doi.org/10.1038/ncomms12859
J
Jonathan D. Proto
Sanofi (France)(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
35
Papers
2.0K
Citations
14
h-index
17
i10-index
Jonathan D. Proto is an academic researcher from Sanofi (France). The author has contributed to research in topics: Muscle Physiology and Disorders & Mesenchymal stem cell research & Immune cells in cancer. The author has an h-index of 14, co-authored 30 publications.
Papers by this author
worksCSF1R signaling is a regulator of pathogenesis in progressive MS
2020 · Cell Death and Disease · 167 citations
https://doi.org/10.1038/s41419-020-03084-7
Role of donor and host cells in muscle‐derived stem cell‐mediated bone repair: differentiation <i>vs.</i> paracrine effects
2014 · The FASEB Journal · 54 citations
https://doi.org/10.1096/fj.13-247965
Deficiency of AXL in Bone Marrow-Derived Cells Does Not Affect Advanced Atherosclerotic Lesion Progression
2016 · Scientific Reports · 11 citations
https://doi.org/10.1038/srep39111
Glucosylceramide synthase modulation ameliorates murine renal pathologies and promotes macrophage effector function in vitro
2024 · Communications Biology · 1 citations
https://doi.org/10.1038/s42003-024-06606-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat